Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGS1 | P23219 | 1/20 | 0.38 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.38 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
| ▸ | RAB9A | P51151 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.33 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.32 |
| ▸ | HPGD | P15428 | 1/20 | 0.30 |
| ▸ | APOBEC3G | Q9HC16 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18674784 | 0.88 | HDAC1 (0.33) | HDAC1 | |
| SCHEMBL15907859 | 0.81 | — | — | |
| SCHEMBL15926092 | 0.81 | PTGS1 (0.36) | PTGS1PTGS2MAPTRAB9AKMT2A | |
| SCHEMBL18866739 | 0.81 | HDAC1 (0.34) | HDAC1 | |
| SCHEMBL2687309 | 0.80 | GRM4 (0.40) | MEN1KMT2AHDAC1HPGD | |
| SCHEMBL2687315 | 0.80 | GRM4 (0.40) | MEN1KMT2AHDAC1HPGD | |
| SCHEMBL18678745 | 0.79 | IDO1 (0.37) | PTGS2MAPT | |
| SCHEMBL10029160 | 0.77 | HDAC1 (0.47) | PTGS1PTGS2MAPTRAB9AHDAC1 | |
| SCHEMBL18785519 | 0.77 | HDAC1 (0.55) | PTGS1PTGS2MEN1MAPTRAB9A | |
| SCHEMBL2685399 | 0.76 | CCR1 (0.48) | PTGS1PTGS2MEN1KMT2AHPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20170092435-A1 | PHOTOELECTRIC CONVERSION ELEMENT, DYE-SENSITIZED SOLAR CELL, METAL COMPLEX DYE, DYE SOLUTION, AND TERPYRIDINE COMPOUND OR ESTERIFIED PRODUCT THEREOF | FUJIFILM CORPORATION (JP) | 2017-03-30 | — | — | US | disclosed |
| US-20160217936-A1 | PHOTOELECTRIC CONVERSION ELEMENT | SHARP KABUSHIKI KAISHA (JP) | 2016-07-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170092435-A1 | PHOTOELECTRIC CONVERSION ELEMENT, DYE-SENSITIZED SOLAR CELL, METAL COMPLEX DYE, DYE SOLUTION, AND TERPYRIDINE COMPOUND OR ESTERIFIED PRODUCT THEREOF | CRY2, CACNA1S, CACNA1E | PTGS1 3888/4885PTGS2 3275/4885MEN1 202/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.